Home 5 Lab Compliance Advisor 5 CLIA-lca 5 CMS Issues Deficiency Letter to Theranos

CMS Issues Deficiency Letter to Theranos

by | Feb 18, 2016

Theranos is once again in the media spotlight due to negative attention it has received from a government regulatory agency. Last year, the U.S. Food and Drug Administration (FDA) released documents indicating its position that Theranos’ nanotainer used for collecting blood samples is a class II medical device and listing concerns about certain aspects of […]

Theranos is once again in the media spotlight due to negative attention it has received from a government regulatory agency. Last year, the U.S. Food and Drug Administration (FDA) released documents indicating its position that Theranos’ nanotainer used for collecting blood samples is a class II medical device and listing concerns about certain aspects of […]

This content is Exclusive to Lab Compliance Advisor Subscribers

Subscribe or Log in for Exclusive Access.